Human Blood Cells Reprogrammed Into Neural Stem Cells Shed Decades of Epigenetic Age
Converting blood cells directly into neural stem cells triggers dramatic epigenetic de-aging, resetting biological age to as little as 5% of donor age.
Summary
Scientists converted human blood cells from donors aged newborn to 101 years into induced neural stem cells (iNSCs) using just two reprogramming factors, SOX2 and cMYC. Remarkably, the resulting cells showed profound epigenetic de-aging — cells from elderly donors retained only 5–13% of their original biological age, as measured by epigenetic clocks. The de-aging process was unexpectedly slow, continuing for weeks even when cell division was blocked. Over time, age-related differences in gene expression between young and old donor cells also disappeared. The iNSCs ultimately lacked typical hallmarks of cellular aging. Intriguingly, full acquisition of a neural stem cell identity extended well beyond when the cells first appeared to be proliferating neural progenitors, suggesting that cellular reprogramming is a much more gradual process than previously appreciated.
Detailed Summary
Epigenetic aging — the progressive chemical modification of DNA that acts as a biological clock — is increasingly recognized as a core driver of age-related decline. The ability to reverse or reset these marks holds major implications for regenerative medicine and our understanding of aging itself. This study examines what happens to the epigenetic age of cells when human blood is directly converted into a completely different cell type: induced neural stem cells (iNSCs).
Researchers at the University of Bonn and RWTH Aachen used overexpression of two transcription factors, SOX2 and cMYC, to reprogram erythroid progenitor cells from donors spanning newborn to 101 years of age. Critically, this was done without passing through a pluripotent (iPSC) intermediate state — a so-called direct conversion approach. Epigenetic aging clocks were used to quantify biological age at multiple time points during and after conversion.
The findings were striking. iNSCs derived from aged donors retained only approximately 13% of original donor age at low cell passages and just 5% at higher passages — a near-complete epigenetic rejuvenation. This de-aging was not instantaneous; it continued gradually over several weeks and persisted even when cell proliferation was chemically inhibited, suggesting the process is not simply diluted out by cell division. Transcriptomic differences between young- and old-donor iNSCs also converged over time. Established iNSC lines lacked canonical age-associated cellular hallmarks. Notably, full neural stem cell identity — as defined by DNA methylation and RNA sequencing signatures — took considerably longer to emerge than the appearance of PAX6-positive proliferating cells might suggest.
These results are significant for longevity science because they demonstrate that direct cellular reprogramming can achieve profound, measurable epigenetic rejuvenation without full pluripotency. The slow, progressive nature of de-aging makes iNSC conversion a powerful model for dissecting the molecular mechanisms of epigenetic age reversal, with potential implications for future rejuvenation therapies. Caveats include reliance on abstract-only data and the absence of functional in vivo validation.
Key Findings
- iNSCs from donors up to 101 years old retained only 5–13% of original donor epigenetic age after conversion.
- Epigenetic de-aging continued for weeks and even when cell proliferation was blocked, ruling out simple dilution.
- Age-related transcriptomic differences between young and old donor cells disappeared with extended conversion time.
- Full neural stem cell identity takes far longer to acquire than the emergence of PAX6-positive proliferating cells suggests.
- Direct conversion without pluripotency can achieve epigenetic rejuvenation comparable to iPSC reprogramming.
Methodology
Erythroid progenitor cells from donors aged newborn to 101 years were directly converted to iNSCs via SOX2 and cMYC overexpression, bypassing pluripotency. Epigenetic age was tracked longitudinally using DNA methylation-based aging clock algorithms, and transcriptomic changes were assessed via RNA sequencing across conversion time points.
Study Limitations
This summary is based on the abstract only, as the full paper is not open access. In vivo functional validation of the de-aged iNSCs is not described in the abstract. The extent to which epigenetic de-aging translates to genuine functional rejuvenation of cell behavior remains to be fully established.
Enjoyed this summary?
Get the latest longevity research delivered to your inbox every week.
Enter your email to subscribe: